I Own SCHD, and I Still Believe in It. Here's Why I Also Bought This 10.5%-Yielding ETF Almost Nobody Knows About.
Source: The Motley Fool
The article highlights SCHD’s trailing 12-month yield of 3.1% and average dividend growth of 9.4% as a core long-term income holding, while proposing a smaller allocation to OVL for higher income. OVL is cited with a trailing 12-month yield of 10.5% and 17.2% average annual total return since inception (vs. 16.2% for the S&P 500 and 13.8% for SCHD), using an options put-spread overlay to fund monthly distributions. The key trade-off noted is higher fees (0.79% expense ratio vs. 0.06% for SCHD) and greater downside risk, making OVL a complement rather than a replacement.
Analysis
This is less a stock-specific catalyst than a positioning signal: retail income capital is still reaching for yield via short-vol structures, which tends to support option-selling product AUM in calm markets but creates latent convexity risk when realized volatility spikes. The real economic winner is not the ETF wrapper so much as the market makers and systematic vol sellers harvesting premium; the loser is the investor who mistakes carry for skill, especially after fees. For equities, the only indirect positive is that these vehicles mechanically maintain some SPX exposure, but that is too small to matter unless flow scales materially from here.
The key second-order issue is regime dependence. Put-credit income works best in grind-up or range-bound tape over the next 1-3 months; it underperforms sharply in a 5%-10% correction because the strategy is effectively short downside tail, even if the lower strike caps the damage. If the VIX mean-reverts higher or the index breaks prior support, the stated “income advantage” can disappear quickly, and the 79 bps fee becomes an obvious drag over 6-18 months.
Contrarian view: the market may be overestimating the persistence of elevated yield from these structures. The headline yield is likely backward-looking and path-dependent, so a lower-vol year can make the fund look brilliant while a normal drawdown makes the distribution appear unstable. For broad-market exposure, the risk-adjusted answer is still a low-cost core ETF; the overlay product is a tactical income sleeve, not a strategic replacement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
Key Decisions for Investors
- Do not chase OVL after a yield-heavy pitch; treat it as a small tactical sleeve only. If entered, scale in on a market pullback, not at momentum highs, because the expected value improves when implied vol is elevated.
- Prefer SCHD or a low-cost core index exposure over OVL for strategic capital. The fee gap alone is a long-horizon performance headwind that likely overwhelms the overlay edge over 3-5 years.
- If the desk wants to express a view on crowded income-chasing, use a relative-value monitor: long low-fee dividend exposure (SCHD) vs. avoid/underweight high-fee short-vol income wrappers like OVL. Falsify if OVL continues to compound through a high-vol regime while preserving distributions.
- Set an alert on VIX and SPX drawdown: if VIX > 20 or SPX falls 5%+ from recent highs, expect OVL-type funds to lag materially and consider reducing exposure before distributions compress.
- For liquid alternatives, favor more established option-income vehicles only if the mandate requires monthly cash flow; otherwise keep the portfolio beta in plain index exposure and source income from dividends, not premium selling.
More News
- OpenAI projected to bring in $20bn less in revenue than expected
- Nasdaq 100: Tech Stocks Find Buyers as Dow Holds Firm Premarket
- Nvidia, Oracle, CoreWeave and other AI stocks sink on OpenAI revenue report
- Nvidia-backed Aussie AI firm Firmus withdraws historic IPO, citing market volatility
- JPMorgan downgrades DuPont stock rating on recovery outlook
- TSMC taps GlobalFoundries to bolster US silicon interposer production in $2B deal